Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 770 of 5804
-
Hope for elderly lung cancer patients: immunotherapy combo under study
Disease control OngoingNon Small Cell Lung Cancer (NSCLC) remains the leading cause of death by cancer in the world. Because of the increase in lung cancer incidence with age and the increase of life expectancy, about half of the patients are patients aged 70 or older. Several clinical trials have show…
Phase: PHASE3 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New One-Shot knee cartilage repair shows promise in trial
Disease control CompletedArticular cartilage defects in the knee have poor intrinsic healing capacity and may lead to functional disability and osteoarthritis. Cartilage cell therapy using autologous chondrocyte implantation has been established as the first advanced treatment therapy medicinal product. …
Phase: PHASE3 • Sponsor: R.J.H. Custers • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
CRISPR-Tweaked donor cells take on Hard-to-Treat blood cancers
Disease control TerminatedThis is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX110 in subjects with relapsed or refractory B-cell malignancies.
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New combo aims to keep stomach cancer at bay longer
Disease control OngoingThis is a randomized phase II study examining nivolumab alone versus radiation therapy with nivolumab in subjects who did not have disease progression to initial therapy with the combination of FOLFOX and Nivolumab.
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Chemo-Free combo shows promise in lung cancer trial
Disease control OngoingThe purpose of this study is to see if Durvalumab and radiation therapy can delay the worsening of disease in patients with non-small cell lung cancer normally treated with sequential chemotherapy followed by radiation therapy.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New combo attack on lung cancer brain metastases shows promise in Real-World study
Disease control OngoingThe goal of this retrospective real-world study is to evaluate the effectiveness and safety of first-line osimertinib combined with early intracranial stereotactic radiotherapy (SRT) in patients with EGFR-mutant non-small cell lung cancer (NSCLC) with symptomatic brain metastases…
Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a monthly shot stop migraines in kids?
Disease control OngoingThis study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to \<12 years) and adolescents (12 to \<18 years) with episodic migraine. The study hypothesis is that in pediatric participants with episodic migraine, the combined erenumab dose g…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could your genes decide when you get a mammogram? major study tests personalized breast cancer screening
Prevention OngoingMyPeBS is an international randomized, open-label, multicentric, study assessing the effectiveness of a risk-based breast cancer screening strategy (using clinical risk scores and polymorphisms) compared to standard screening (according to the current national guidelines in each …
Phase: NA • Sponsor: UNICANCER • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
New combo before surgery may boost pancreatic cancer outcomes
Disease control Recruiting nowThe purpose of this phase 2 research study is to determine whether a combination of chemotherapy drugs plus radiation therapy, given before surgery in resectable pancreactic cancer, can help to increase the chances of surgeons achieving and R0 resection. The chemotherapy drugs us…
Phase: PHASE2 • Sponsor: Loma Linda University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New antibody treatment aims to keep myeloma in check after transplant
Disease control OngoingThis phase II trial studies how well daratumumab after a stem cell transplant works in treating patients with multiple myeloma. Monoclonal antibodies, such as daratumumab, may kill cancer cells that are left after chemotherapy.
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New hope for cancer patients with autoimmune conditions: immune checkpoint inhibitor trial expands access
Disease control Recruiting nowThis phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer th…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy aims to shrink advanced tumors
Disease control Recruiting nowThis phase II trial studies the side effects of durvalumab when given together with chemotherapy in treating patients with solid tumors that have spread to other places in the body (advanced). Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immun…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Radioactive antibody targets rare childhood cancer
Disease control OngoingThe purpose of this study is to test any good and bad effects of the study drug 131I-omburtamab. 131I-omburtamab could prevent the cancer from returning, or delay the cancer from getting worse, but it could also cause side effects. Researchers hope to learn more about how 131I-om…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Gene therapy for rare Sugar-Storage disease shows promise in Long-Term safety check
Disease control CompletedThe primary objective of this study is to determine the long-term safety of DTX401 following a single intravenous (IV) dose in adults with GSDIa.
Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New study aims to find best heart attack care for seniors with multiple blockages
Disease control OngoingElderly patients presenting with myocardial infarction (MI) and multivessel disease are the highest risk population with the worst prognosis. No trial has ever been designed to optimize their outcome. The actual real-life standard of care is, in the best of the cases, culprit onl…
Phase: NA • Sponsor: Consorzio Futuro in Ricerca • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Triple chemo cocktail shows promise against tough pancreatic cancer
Disease control CompletedThis is a phase II open-label study evaluating the efficacy and safety of nab-paclitaxel cisplatin, and gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma.
Phase: PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New program tackles depression and HIV together in rural zimbabwe
Disease control CompletedA hybrid effectiveness-efficacy trial to evaluate a stepped care task shifted intervention to treat depression and HIV medication nonadherence in low resource settings in rural Zimbabwe.
Phase: NA • Sponsor: King's College London • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug may help keep leukemia away after transplant
Disease control Recruiting nowThis phase II trial studies the side effects of using enasidenib as maintenance therapy in treating patients with acute myeloid leukemia with IDH2 mutation following donor stem cell transplant. Enasidenib may stop the growth of cancer cells by blocking some of the enzymes needed …
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for rare blistering disease: rituximab vs standard therapy
Disease control OngoingMucous membrane pemphigoid (MMP) describes a group of chronic auto-immune bullous diseases (AIBD) of the basement membrane zone (BMZ), characterized by predominant or exclusive mucosal involvement, including oral, naso-pharyngeal, laryngo-tracheal, genital, oesophageal, anal and …
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Brain pacemaker that learns: new trial aims to personalize Parkinson's treatment
Disease control ENROLLING_BY_INVITATIONThis study involves patients who are already planning to have deep brain stimulation (DBS) surgery to treat the symptoms of severe Parkinson's Disease (PD). The study has two goals: 1. to evaluate the effectiveness of implanting DBS electrodes in the two most common locations fo…
Phase: NA • Sponsor: Dennis Turner, M.D. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC